First Time Loading...
A

Aquestive Therapeutics Inc
NASDAQ:AQST

Watchlist Manager
Aquestive Therapeutics Inc
NASDAQ:AQST
Watchlist
Price: 3.1 USD 1.31% Market Closed
Updated: May 29, 2024

P/E
Price to Earnings

-9.7
Current
-2.5
Median
22.8
Industry
Lower than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-9.7
=
Market Cap
280.5m
/
Net Income
-28.8m
All Countries
Close
Earnings Growth
US
A
Aquestive Therapeutics Inc
NASDAQ:AQST
Average P/E: 54.7
Negative Multiple: -9.7
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
125.1
364%
DK
Novo Nordisk A/S
CSE:NOVO B
45.7
83%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
US
Johnson & Johnson
NYSE:JNJ
9
-21%
US
Merck & Co Inc
NYSE:MRK
138.5
7 598%
UK
AstraZeneca PLC
LSE:AZN
37.6
175%
CH
Roche Holding AG
SIX:ROG
15.9
28%
CH
Novartis AG
SIX:NOVN
11.1
17%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -519
683%

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-5.6
2-Years Forward
P/E
-6.7
3-Years Forward
P/E
-10.4

See Also

Discover More